MedTrace Logo

Venetoclax Registry

NCT03662724 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-02-16

No results posted yet for this study

Summary

Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Course in the Treatment of Acute Myeloid Leukemia With Venetoclax

Conditions

Interventions

DRUG

Venetoclax

Registry study observing clinical and biological characteristics of patients with acute myeloid leukemia who are treated with Venetoclax.

Sponsors & Collaborators

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Michael Heuser, MD · Hannover Medical School

  • Rabia Shahswar, MD · Hannover Medical School

  • Gernot Beutel, MD · Hannover Medical School

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2021-11-01
Completion
2025-11-01
FDA Drug
Yes

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03662724 on ClinicalTrials.gov